Two Sigma Securities’s Tectonic Therapeutic TECX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-873
Closed -$13.4K 3798
2024
Q1
$13.4K Buy
+873
New +$13.8K ﹤0.01% 2727
2023
Q1
Sell
-1,180
Closed -$10.1K 3401
2022
Q4
$10.1K Buy
+1,180
New +$10.4K ﹤0.01% 2357

Other funds holding TECX

Two Sigma Securities's TECX Position: Q2 2024 in Review

Two Sigma Securities sold out of Tectonic Therapeutic (TECX) in Q2 2024, closing a stake of 873 shares — an estimated $13.4K sold.

Two Sigma Securities first reported a position in TECX in Q4 2022 and held it in 2 quarters. The position peaked at $13.4K in Q1 2024. 40 funds tracked by Wall St. Rank hold TECX as of Q2 2024.

  • Two Sigma Securities reported no remaining Tectonic Therapeutic position as of Q2 2024 after selling out during the quarter.
  • Two Sigma Securities sold 873 Tectonic Therapeutic shares in Q2 2024, an estimated $13.4K.
  • Two Sigma Securities first reported a position in Tectonic Therapeutic in Q4 2022 and held it in 2 quarters.
  • Two Sigma Securities's Tectonic Therapeutic position peaked at $13.4K in Q1 2024.
  • 40 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q2 2024.

Based on Two Sigma Securities's 13F filing for Q2 2024, filed 14 Aug 2024.